Company intelligence / Profile preview

Maven Biotechnologies

Pasadena, California, United Statesprnewswire.com ↗

Ownership: Private
Employees: ~10
Development stage: Preclinical

Overview

Maven Biotechnologies has developed LFIRE™, a patented real-time imaging platform enabling quantitative, label-free cell-based assays and multiplexed biomarker detection. Their products address needs in biomedical research, drug discovery, biological manufacturing and immunodiagnostics. The company has received NIH funding to commercialize its technology.

Industry: Medical Imaging

Partnerships

National Institutes of Health

Beyond the preview

Go deeper on Maven Biotechnologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Maven Biotechnologies.

Explore the full profile